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Many risk factors for progression in immunoglobulin A
nephropathy (IgAN) have been found. We focused on renal
leukocyte infiltrations and cytokines in IgAN. The subjects
were 204 IgAN patients. Renal histopathological changes
were semiquantitatively graded. Expression of
tubulointerstitial Leukocyte common antigen (LCA), CD3,
CD68, interleukin (IL)-1b, and IL-10 was evaluated by
immunohistochemistry. These parameters were correlated
with progression of IgAN. The significance of these
correlations was tested by a multivariate analysis.
Glomerulosclerosis, tubular atrophy, interstitial inflammation,
and hyaline arteriolosclerosis correlated with progression in
all patients and also in patients with initially normal serum
creatinine. Tubulointerstitial LCA, CD3, CD68, and IL-1b
expression correlated with progression. CD3 had the
strongest correlation. In the multivariate analysis,
tubulointerstitial CD3, hypertriglyceridemia, elevated serum
creatinine concentration, and interstitial fibrosis were
independently associated with progressive disease in all
patients, and tubulointerstitial CD3 expression and hyaline
arteriolosclerosis in patients with initially normal serum
creatinine. We found parameters reflecting tubulointerstitial
inflammation to predict deterioration of renal function in
IgAN. This was also seen in patients whose serum creatinine
was normal at the time of renal biopsy. Our findings show
that, an immunohistochemical evaluation of tubulointerstitial
inflammation seems to be a useful tool in determining the
prognosis in IgAN.
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Immunoglobulin A nephropathy (IgAN) is an immune-
mediated glomerulonephritis of unknown etiology and
variable outcome.1,2 Even though the pathogenetic mechan-
isms are as yet unclear, it is commonly accepted that severe
proteinuria, increased serum creatinine concentration, and
hypertension predict poor prognosis in IgAN. Recently we
also found hyperuricemia and hypertriglyceridemia to be risk
factors for the progression of IgAN.3
A variety of grading systems have been developed for
classifying histopathological changes in renal biopsies from
IgAN patients. According to the studies in question severe
glomerulosclerosis and chronic tubulointerstitial changes are
probably the strongest histopathological risk factors for poor
outcome in IgAN. We recently found that high uric acid
levels are associated independently with tubulointerstitial
damage in IgAN.4
Leukocyte common antigen (LCA) is expressed on white
blood cells. We recently evaluated immunohistochemically
LCA expression to detect leukocyte infiltrations in renal
tubulointerstitial tissue in IgAN. The expression strongly
correlated with tubular atrophy and interstitial inflammation
seen in renal biopsy.4 An increase in the expression of T-
lymphocyte marker, CD3, would appear to be associated with
a rapidly progressive course of IgAN.5 Prominent macro-
phage infiltrations in human kidney tissue, found by staining
CD68, have been reported in the context of aggressive forms
of glomerulonephritis.6 Crescents in IgAN are associated with
CD68 positivity of renal tissue.7
Interleukin-1b (IL-1b) is a proinflammatory cytokine,
which triggers the inflammatory process by activating
wide range of inflammatory mediators. Typically IL-1b is
produced by activated macrophages.8 IL-10 is an
anti-inflammatory cytokine, which also suppresses IL-1b
synthesis.9
In this study, we investigated the predictive role
of inflammatory parameters as compared with conventional
histopathological and clinical factors in IgAN. The
main interest focused on tubulointerstitial T lympho-
cytes (CD3), macrophages (CD68), and proinflammatory
and anti-inflammatory cytokines (IL-1b and IL-10) as
well as their associations with the natural course
of IgAN.
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RESULTS
Univariate associations of histopathological parameters with
progression in IgAN
Histopathological findings are listed in Table 1. Correlations
between histopathological parameters and progression are
summarized in Table 2. Glomerulosclerosis, tubular atrophy,
interstitial inflammation, interstitial fibrosis (IF), and hyaline
arteriolosclerosis were found to be associated with progres-
sion in all IgAN patients. All these factors except IF were also
associated significantly with progression in the subgroup of
patients with normal serum creatinine at the time of renal
biopsy.
Univariate associations of tubulointerstitial LCA, CD3, and
CD68 expressions with progression and clinical parameters in
IgAN
Correlations between immunohistochemically studied para-
meters and progression are summarized in Table 3. Tubu-
lointerstitial CD3 and LCA expressions correlated
significantly with the degree of urine protein excretion
(UPE). Tubulointerstitial CD3 also correlated with serum
levels of uric acid and creatinine, but not with blood
pressure. Tubulointerstitial CD68 expression also correlated
significantly with UPE and serum creatinine. We found the
level of tubulointerstitial CD3 expression to be associated
most strongly with progression in all patients with IgAN
(Figure 1), but also in the subgroup of patients with initially
normal serum creatinine. Likewise tubulointerstitial LCA,
also CD68 (Figure 2) correlated significantly with progres-
sion.
Univariate associations of tubulointerstitial IL-1b and IL-10
immunoreactivity with progression, histopathological, and
clinical parameters in IgAN
Cytokines IL-1b and IL-10 were mainly expressed in tubular
epithelial cells. Expression of IL-10 was markedly more
prominent than the IL-1b expression (Po0.001). Both IL-1b
and IL-10 correlated significantly with CD3 (Po0.001,
Po0.01) and CD68 (Po0.001, Po0.001) expression.
Immunoreactivity of IL-1b also correlated with LCA expres-
sion (Po0.05), and equally with IF (Po0.05).
Initial serum creatinine concentration correlated with
IL-1b expression (Po0.01). Patients with progressive disease
had a more prominent IL-1b expression than patients
with stable disease (Po0.01) (Table 3) (Figure 3). A positive
association with progression was also present when
investigating the subgroup of patients with initially normal
serum creatinine. We found no correlation between initial
serum creatinine or progression and IL-10 expression.
Table 1 | Histopathological findings in 204 patients with IgAN
and in 166 IgAN patients with initially normal serum
creatinine
Finding
All patients, n
(%)
Patients with
initially normal
serum creatinine, n
(%)
Glomeruli
Normal morphology or
minimal lesions
12 (6) 10 (6)
Mesangial cellularity
Mild hypercellularity 94 (47) 81 (49)
Marked hypercellularity 46 (23) 42 (25)
Glomerulosclerosis
Mild 126 (62) 104 (63)
Marked 52 (26) 38 (23)
Tubulointerstitial tissue
Normal morphology 92 (46) 88 (53)
Tubular atrophy
Mild 59 (29) 47 (28)
Marked 21 (10) 10 (6)
IF
Mild 39 (19) 26 (16)
Marked 22 (11) 12 (7)
Interstitial inflammation
Mild 45 (22) 33 (20)
Marked 7 (3) 1 (1)
Vascular tissue
Normal morphology 80 (40) 69 (42)
Hyaline arteriolosclerosisa 84 (42) 66 (40)
Arterial intimafibrosisa 81 (40) 63 (38)
IF, interstitial fibrosis; IgAN, IgA nephropathy.
aMild, moderate, or marked.
Table 2 | Correlations of histopathological parameters with progressive disease in patients with IgAN
Histopathological parameter
All patients, n=204
Patients with initially normal serum
creatinine, n=166
Progressive disease,
n=41
Stable disease,
n=163
Progressive disease,
n=27
Stable disease,
n=139
Mesangial cellularity, No/Mi/Ma (%) 34/37/29 29/49/22 22/41/37 27/50/23
Glomerulosclerosis, No/Mi/Ma (%) 5/46/49 14/66/20** 7/41/52 16/67/17***
Tubular atrophy, No/Mi/Ma (%) 39/37/24 66/27/7** 48/37/15 69/27/4*
Interstitial inflammation, No/Mi/Ma (%) 56/34/10 79/19/2** 63/33/4 83/17/0*
IF, No/Mi/Ma (%) 46/27/27 76/17/7*** 63/22/15 80/14/6
Hyaline arteriolosclerosis, No/Mi/Ma (%) 49/7/44 61/25/14*** 52/4/44 62/27/11***
Arterial intimafibrosis, No/Mi/Ma (%) 51/22/27 62/19/19 44/26/30 66/20/14
IF, interstitial fibrosis; IgAN, IgA nephropathy; No/Mi/Ma, normal/mild/marked.
*Po0.05, **Po0.01, ***Po0.001.
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Associations of histopathological and immunohistochemical
parameters with progression of IgAN in multivariate
analysis
To find histopathological and immunohistochemical para-
meters most strongly associated with progression in IgAN, we
included all the aforementioned univariately correlating
factors in the same multivariate analysis model. We found
glomerulosclerosis (Po0.05), IF (Po0.01) and tubulointer-
stitial CD3 (Po0.001) to be most strongly associated with
progression in all IgAN patients and hyaline arteriolosclerosis
(Po0.05), tubulointerstitial CD3 (Po0.001), and IL-1b
(Po0.05) expressions in the case of patients with initially
normal serum creatinine.
IF, glomerulosclerosis, and tubulointerstitial CD3 were
included in the same multivariate analysis model together
with proteinuria (41g/24 h), hypertension, increased serum
creatinine concentration, hyperuricemia, and hypertriglycer-
idemia when investigating all patients. We found hypertri-
glyceridemia (Po0.05), increased serum creatinine
concentration (Po0.05), IF (Po0.05), and tubulointerstitial
CD3 expression (Po0.001) to be independently associated
with progression.
To annul the influence of initial renal insufficiency in the
risk factor analysis, we studied patients with initially normal
serum creatinine separately. Tubulointerstitial CD3, IL-1b,
Table 3 | Correlations of tubulointerstitial expressions of CD3, CD68, LCA, IL-1b, and IL-10 with progressive disease in patients
with IgAN
Histopathological parameter
All patients, n=176 Patients with initially normal serum creatinine, n=146
Progressive disease,
n=34
Stable disease,
n=142
Progressive disease,
n=24
Stable disease,
n=122
CD3, mean (2 s.d.) 99.5 (208.8) 34.4 (132.8)*** 86.7 (200.5) 22.1 (55.2)***
CD68, mean (2 s.d.) 290.2 (351.1) 195.7 (334.3)** 288.0 (360.4) 164.1 (230.9)**
LCA, mean (2 s.d.) 18.5 (34.3) 8.3 (17.1)*** 20.6 (38.7) 7.30 (13.8)***
IL-1b, mean (2 s.d.) 1.62 (2.70) 0.95 (1.90)** 1.52 (2.72) 0.83 (1.72)*
IL-10, mean (2 s.d.) 2.74 (3.28) 2.26 (2.56) 2.80 (3.10) 2.19 (2.52)
IgAN, IgA nephropathy; IL, interleukin; LCA, leukocyte common antigen; s.d., standard deviation.
*Po0.05, **Po0.01, ***Po0.001.
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Figure 1 | Tubulointerstitial CD3 expression in patients with IgAN
with stable or progressive course of renal disease. The line across
the box indicates the median. The box represents the interquartile
(IQ) range, which contains the middle 50% of the records. The
whiskers are lines extending from the upper and lower edge of the
box to the highest and lowest values, which are no greater than 1.5
times the IQ range.
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Figure 2 | Tubulointerstitial CD68 expression in patients with
IgAN with stable or progressive course of renal disease. The line
across the box indicates the median. The box represents the
interquartile (IQ) range, which contains the middle 50% of the
records. The whiskers are lines extending from the upper and lower
edge of the box to the highest and lowest values, which are no
greater than 1.5 times the IQ range.
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Figure 3 | Tubulointerstitial IL-1b expression in patients with
IgAN with stable or progressive course of renal disease. The line
across the box indicates the median. The box represents the
interquartile (IQ) range, which contains the middle 50% of the
records. The whiskers are lines extending from the upper edge of the
box to the highest values, which are no greater than 1.5 times the IQ
range.
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hyaline arteriolosclerosis, hypertension, proteinuria, hyper-
triglyceridemia, and hyperuricemia were parameters in the
model for multivariate analysis. Tubulointerstitial CD3
expression (Po0.001) and hyaline arteriolosclerosis
(Po0.05) were found to be independently associated with
progression in that subgroup of patients.
DISCUSSION
Previously many clinical and histopathological risk factors
have been found to predict poor prognosis in IgAN. Recently
published review articles provide summaries of these
factors.1,10 Severe glomerulosclerosis and especially severe
tubulointerstitial damage are histopathological parameters
most powerfully associated with progression. In this study,
we found parameters reflecting tubulointerstitial inflamma-
tion to be strongly associated with progression of renal
disease in IgAN.
In addition to glomerular, chronic tubulointerstitial
changes such as tubular atrophy and IF are often seen in
renal biopsies from patients with IgAN.11 However, inflam-
matory cell infiltrations, which have been classified as a
marker of an active phase in renal disease, may also be
present in biopsy specimens from a patient with IgAN.12 In
this study, half of the patients had significant tubulointer-
stitial histopathological lesions in renal biopsy. A significant
extent of interstitial inflammation was found in 25% of
specimens. Chronic tubulointerstitial lesions have usually
been associated with poor prognosis in IgAN.10 Much less
attention has been paid to inflammatory cell infiltrations,
even though Freese et al.13 found the presence of interstitial
cellular infiltrates to be a high-risk factor in IgAN.
In this study, we found the severity of interstitial
inflammation to be associated with progression of IgAN.
Active inflammation in inflammatory diseases is commonly
depressed by corticosteroids. Corticosteroid treatment has
been found to improve the clinical picture in IgAN.14,15
These findings may be attributable especially to the positive
effect of corticosteroids to patients with active inflammation
in renal tissue.
LCA has an important role in the functions of inflamma-
tory cells.16 By staining LCA (CD45) in a tissue sample the
localization of white blood cells can be established. Study of
LCA alone cannot differentiate the levels of chronic and acute
inflammation. In this study, we made quantitative determi-
nations of renal inflammation by staining LCA in the
tubulointerstitium of patients with IgAN. Tubulointerstitial
LCA correlated significantly with the prognosis of renal
function.
T lymphocytes typically express CD3 antigen. By evaluat-
ing the level of CD3þ cell infiltration, it is possible to
approximate the intensity of inflammation in human tissue.
Infiltrations of CD3þ cells have been linked to the
development of IF in glomerulonephritis and to significant
elevation of serum creatinine concentration in IgAN.17,18 Falk
et al.5 found that prominent expression of CD3 in renal tissue
from patients with IgAN occurred commonly in the rapidly
progressive type of disease. However, the follow-up time in
aforementioned study was quite short and the number of
patients rather small. In the present study, with longer post-
biopsy follow-up and a larger patient population, we found a
particularly strong correlation between the amount of
CD3þ cell infiltrations and progression of IgAN. We also
found tubulointerstitial CD3 expression to be independently
associated with progression when studying in the same
multivariate analysis model with the most essential clinical,
biochemical, and histopathological parameters. Hypertrigly-
ceridemia, initially elevated serum creatinine concentration
and IF were also found to be independent risk factors in all
IgAN patients. When studying patients with initially normal
serum creatinine, hyaline arteriolosclerosis, and tubulointer-
stitial C3D expression were independently associated with
progression.
Prominent infiltrations of macrophages with significant
proliferation seem to be more common in the aggressive type
of glomerulonephritis (Yang, 1998 No.264). In pediatric
IgAN patients the level of CD68þ macrophage infiltrations
in the interstitium correlates significantly with urinary
macrophage count, which further correlates with the activity
of renal disease and UPE.19 In this study, with mainly adult
patients, expression of CD68 in the tubulointerstitium
correlated significantly with the level of UPE and serum
creatinine concentration, but also with progression.
Cytokine IL-1b promotes inflammation by activating a
wide range of chemokines, enzymes, other cytokines and
leukocyte adhesion molecules.8 Activated macrophages are
the main source of IL-1b. We found IL-1b expression to
correlate with the amount of tubulointerstitial CD3þ and
CD68þ cells. However, intrinsic cells seem to be the main
source of IL-1b in kidney, where it seems to be involved in
the disease processes in many levels.20,21 We found IL-1b
expression mainly in tubular epithelial cells. This expression
correlated significantly with progression rate. It was also
associated with previously established high-risk factors, IF
and initial serum creatinine concentration. As an anti-
inflammatory cytokine, IL-10 suppresses inflammation
among other mechanisms by decreasing IL-1b synthesis.
Intrarenal IL-10 expression in IgAN patients occurs mainly in
tubular regions.22 This was also the case in our study.
Although IL-10 was more prominently expressed than IL-1b,
we found no correlation between IL-10 expression and
clinical or histopathological risk factors for progression or
with progression of IgAN.
In summary, this results show that in addition to
risk factors previously found, inflammation also predicts a
poor course of renal disease in IgAN. Immunohistochem-
istry, especially investigating tubulointerstitial CD3þ T-
lymphocyte infiltrations and the expression of IL-1b, proved
to be a useful tool in predicting the prognosis in
these patients. By evaluating the level of inflammation in
renal tissue the medical treatment may be more accurately
targeted to those patients who may derive the most
significant benefit.
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MATERIALS AND METHODS
Patients
The original patient population was the same as in our previous
studies.4,23 It comprised all 223 IgAN patients diagnosed in Tampere
University Hospital during a period of 11 years from January 1980
to December 1990. The renal biopsy specimens from 204 patients
contained four or more glomeruli and were considered representa-
tive for the present analyses. IgAN was diagnosed when IgA was the
sole or predominant glomerular IF finding in the biopsy. Of all
IgAN cases 131 (64%) were men and 73 (36%) women. Their
median age was 41 years (range, 16–78) at the time of renal biopsy;
166 patients had normal serum creatinine at the time of renal
biopsy. The Ethical committee of Tampere University Hospital has
approved this study.
Clinical definitions
Serum creatinine values p125 mmol/l in men or p105 mmol/l in
women were considered normal. Progression in renal disease was
defined as an elevation of serum creatinine value above the normal
limit and over 20% from baseline.3 Blood pressure was measured by
sphygmomanometer after rest. Hypertension was defined as systolic
blood pressure over 140 mmHg and/or diastolic blood pressure over
90 mmHg or usage of antihypertensive medication. UPE measure-
ments were based on 24 h collection of urine. Proteinuria was
defined as UPE 1g/24 h or more. Serum uric acid was measured in
172 (84%) patients. Hyperuricemia was defined as serum uric acid
40.45 mmol/l in men and 40.34 mmol/l in women. Two patients
were using allopurinol for gout. Serum triglyceride values were
studied in 173 (85%) and were measured enzymatically after an
overnight fast at the time of biopsy. Hypertriglyceridemia was
defined as serum triglyceride concentration over 1.7 mmol/l. None
of the patients was using lipid-lowering medication at the time of
biopsy.
The follow-up ended at the time of a control visit performed
during years 1996–1997 or if the patient died. The median follow-up
time after renal biopsy was 10 years (range, 0.2–17).
Renal pathological evaluation
Paraffin sections for light microscopy were stained by the
hematoxylin–eosin, periodic acid-Schiff reaction, Masson’s tri-
chrome, and periodic acid silver methenamine methods. Mesangial
cellularity, glomerulosclerosis, tubular atrophy, IF and inflamma-
tion, hyaline arteriolosclerosis, and arterial intimafibrosis were
evaluated and semiquantitatively graded into three groups as
normal, mild and marked as in our previous study.4 Histopatho-
logical evaluation was made by one investigator who was not aware
of the clinical data.
Immunohistochemistry
Tissue specimens were available from 176 patients for immunohis-
tochemistry, 146 of them having initially normal renal function.
Renal tissue was available from 163 patients for IL-1b and IL-10
studies. For light microscopic immunoperoxidase staining, 3-mm
paraffin sections were cut onto ChemMateTM capillary gap micro-
scope slides (DakoCytomation, Denmark A/S). Inflammatory cells
were investigated by staining the CD45 (DakoCytomation, Denmark
A/S, leukocyte common antigen, LCA, clone 2B11þPD7/26)
(1:2000), CD3 (Novocastra Laboratories Ltd, clone NCL-CD3-
PS1) (1:100) and CD68 (DakoCytomation, Denmark A/S, clone PG-
M1) (1:150) antigens identifying lymphocytes and macrophages,
respectively. Monoclonal mouse antibodies to IL-1b (Abcam,
Cambridge, UK, clone 11E5) (1:200) and IL-10 (Serotec, Oxford,
UK, clone B-S10) (1:100) were used to study the intrarenal
expression of these cytokines.
Antigen retrieval was performed on re-hydrated sections in a
microwave oven at 850 W for two 7-min cycles using Tris-
ethylenediaminetetraacetic acid buffer (pH 9.0) as retrieval solution
with CD45, CD3, and CD68 antibodies. Enzymatic digestion with
0.01% trypsin (Sigma, St Louis, MO, USA) in phosphate-buffered
saline (pH 7.4) was used with IL-1b and IL-10 antibodies for 10 min
at 371C. Immunostaining was carried out in a TechMateTM 500
Immunostainer (DakoCytomation, Denmark A/S) using the En-
VisionTM polymer technique (DakoCytomation, Denmark A/S).
Diaminobenzidine was used as chromogen and hematoxylin as
nuclear stain. The specificity of immunohistochemistry was
controlled by omitting the primary antibodies or replacing them
with irrelevant antisera. Known positive tissue samples were also
used to confirm the staining reliability of all separate staining
batches.
Quantification of immunohistochemically stained cells
Immunoperoxidase staining results were investigated at  400
magnification with an ocular grid (0.0625 mm2). The area of
tubulointersitium was determined by point counting using a 100-
point square lattice in the eyepiece. Tubulointerstitial LCA, CD3,
and CD68-positive cells per mm2 were counted from cortical area in
10 adjacent fields. Fields presenting cortical scarring were excluded.
The expression of IL-1b and IL-10 was graded from 0 to 5
according to the following scale: 0¼ no immunoreactivity/no
positive cells; 1¼ faint immunoreactivity in single positive cells;
2¼ clear immunoreactivity in single positive cells; 3¼ scattered
moderately intense reactivity/numerous positive cells; 4¼ dense
intense immunoreactivity/focal clusters of positive cells; 5¼ dense
intense immunoreactivity/numerous clusters of positive cells.
Statistics
Mann–Whitney U or Kruskall–Wallis test was used to find significant
associations of histopathological or clinical factors with immuno-
histochemical parameters when appropriate. Differences between
categorical variables were tested by w2-test or Fisher’s exact test when
appropriate. Multivariate stepwise Cox proportional hazard regres-
sion analysis was used in detecting independent risk factors for
progression. Po0.05 was considered significant for all tests. The
software used for statistical analysis was SPSS for Windows 9.0.
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